The Scientist

» vitamin D

Most Recent

image: Mutagens and Multivitamins

Mutagens and Multivitamins

By | June 1, 2014

Not one to shy away from controversy, Bruce Ames has pitted himself against industry groups, environmentalists, and his peers through his work identifying DNA mutagens. And he’s not done yet.

7 Comments

Contributors

October 1, 2012

Meet some of the people featured in the October 2012 issue of The Scientist.

0 Comments

image: Suspected Effects of Vitamin D

Suspected Effects of Vitamin D

By | March 1, 2012

Vitamin D has a variety of actions in the body. It binds to the vitamin D receptor (VDR), which then binds to the retinoid X receptor (RXR) and activates the expression of numerous genes. 

0 Comments

image: Tricky Trials

Tricky Trials

By | March 1, 2012

Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.

0 Comments

image: Vitamin D on Trial

Vitamin D on Trial

By | March 1, 2012

Prevention trials for vitamins and supplements are notoriously difficult, but some researchers aren’t giving up on finding proof that vitamin D helps ward off disease.

52 Comments

Inside the mind of Fritz Kahn

By | February 1, 2011

For more than 40 years, German gynecologist and legendary science writer Fritz Kahn (1888-1968) captured the imagination of an international audience with hundreds of wildly inventive illustrations and more than a dozen popular science books. 

0 Comments

image: Light Therapy, circa 1939

Light Therapy, circa 1939

By | February 1, 2011

Around the turn of the 20th century—before sunscreens hit the market and the damaging effects of UV radiation were widely appreciated—physicians saw the sun mostly as a source of healing. 

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham